Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association.
Antman
Elliott M
EM
Brigham and Women's Hospital, Harvard Medical School, USA.
Bennett
Joel S
JS
Daugherty
Alan
A
Furberg
Curt
C
Roberts
Harold
H
Taubert
Kathryn A
KA
D000700:Analgesics / Q000009:adverse effects / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000517:prevention & control; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D019468:Disease Management; D004347:Drug Interactions; D004348:Drug Labeling; D017007:Duty to Warn; D004487:Edema / Q000139:chemically induced; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D009140:Musculoskeletal Diseases / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011448:Prostaglandin Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000139:chemically induced* / Q000517:prevention & control; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration
D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002316:Cardiotonic Agents; D052246:Cyclooxygenase 2 Inhibitors; D010975:Platelet Aggregation Inhibitors; D011448:Prostaglandin Antagonists